skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The Fission Converter-Based Epithermal Neutron Irradiation Facility at the Massachusetts Institute of Technology Reactor

Abstract

A new type of epithermal neutron irradiation facility for use in neutron capture therapy has been designed, constructed, and put into operation at the Massachusetts Institute of Technology Research Reactor (MITR). A fission converter, using plate-type fuel and driven by the MITR, is used as the source of neutrons. After partial moderation and filtration of the fission neutrons, a high-intensity forward directed beam is available with epithermal neutron flux [approximately equal to]10{sup 10} n/cm{sup 2}.s, 1 eV {<=} E {<=} 10 keV, at the entrance to the medical irradiation room, and epithermal neutron flux = 3 to 5 x 10{sup 9} n/cm{sup 2}.s at the end of the patient collimator. This is currently the highest-intensity epithermal neutron beam. Furthermore, the system is designed and licensed to operate at three times higher power and flux should this be desired. Beam contamination from unwanted fast neutrons and gamma rays in the aluminum, polytetrafluoroethylene, cadmium and lead-filtered beam is negligible with a specific fast neutron and gamma dose, D{sub {gamma}}{sub ,fn}/{phi}{sub epi} [less than or approximately equal] 2 x 10{sup -13} Gy cm{sup 2}/n{sub epi}. With a currently approved neutron capture compound, boronophenylalanine, the therapeutically advantageous depth of penetration is >9 cm formore » a unilateral beam placement. Single fraction irradiations to tolerance can be completed in 5 to 10 min. An irradiation control system based on beam monitors and redundant, high-reliability programmable logic controllers is used to control the three beam shutters and to ensure that the prescribed neutron fluence is accurately delivered to the patient. A patient collimator with variable beam sizes facilitates patient irradiations in any desired orientation. A shielded medical room with a large window provides direct viewing of the patient, as well as remote viewing by television. Rapid access through a shielded and automatically operated door is provided. The D{sub 2}O cooling system for the fuel has been conservatively designed with excess capacity and is fully instrumented to ensure detection and control of off-normal conditions. A wide range of possible abnormal events or accident scenarios has been analyzed to show that even in the worst cases, there should be no fission product release through fuel damage. This facility has been licensed to operate by the U.S. Nuclear Regulatory Commission, and initial operation commenced in June 2000.« less

Authors:
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2]
  1. Massachusetts Institute of Technology (United States)
  2. Beth-Israel Deaconess Medical Center (Israel)
Publication Date:
OSTI Identifier:
20804769
Resource Type:
Journal Article
Journal Name:
Nuclear Science and Engineering
Additional Journal Information:
Journal Volume: 140; Journal Issue: 3; Other Information: Copyright (c) 2006 American Nuclear Society (ANS), United States, All rights reserved. http://epubs.ans.org/; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0029-5639
Country of Publication:
United States
Language:
English
Subject:
73 NUCLEAR PHYSICS AND RADIATION PHYSICS; ALUMINIUM; BEAM MONITORS; CADMIUM; CAPTURE; CONTROL SYSTEMS; COOLING SYSTEMS; EPITHERMAL NEUTRONS; FAST NEUTRONS; FISSION; FISSION NEUTRONS; GAMMA RADIATION; HEAVY WATER; IRRADIATION; KEV RANGE; MITR REACTOR; NEUTRON CAPTURE THERAPY; NEUTRON FLUENCE; NEUTRON REACTIONS; PATIENTS; POLYTETRAFLUOROETHYLENE

Citation Formats

Harling, O K, Riley, K J, Newton, T H, Wilson, B A, Bernard, J A, Hu, L-W, Fonteneau, E J, Menadier, P T, Ali, S J, Sutharshan, B, Kohse, G E, Ostrovsky, Y, Stahle, P W, Binns, P J, Kiger, III, W S, and Busse, P M. The Fission Converter-Based Epithermal Neutron Irradiation Facility at the Massachusetts Institute of Technology Reactor. United States: N. p., 2002. Web.
Harling, O K, Riley, K J, Newton, T H, Wilson, B A, Bernard, J A, Hu, L-W, Fonteneau, E J, Menadier, P T, Ali, S J, Sutharshan, B, Kohse, G E, Ostrovsky, Y, Stahle, P W, Binns, P J, Kiger, III, W S, & Busse, P M. The Fission Converter-Based Epithermal Neutron Irradiation Facility at the Massachusetts Institute of Technology Reactor. United States.
Harling, O K, Riley, K J, Newton, T H, Wilson, B A, Bernard, J A, Hu, L-W, Fonteneau, E J, Menadier, P T, Ali, S J, Sutharshan, B, Kohse, G E, Ostrovsky, Y, Stahle, P W, Binns, P J, Kiger, III, W S, and Busse, P M. 2002. "The Fission Converter-Based Epithermal Neutron Irradiation Facility at the Massachusetts Institute of Technology Reactor". United States.
@article{osti_20804769,
title = {The Fission Converter-Based Epithermal Neutron Irradiation Facility at the Massachusetts Institute of Technology Reactor},
author = {Harling, O K and Riley, K J and Newton, T H and Wilson, B A and Bernard, J A and Hu, L-W and Fonteneau, E J and Menadier, P T and Ali, S J and Sutharshan, B and Kohse, G E and Ostrovsky, Y and Stahle, P W and Binns, P J and Kiger, III, W S and Busse, P M},
abstractNote = {A new type of epithermal neutron irradiation facility for use in neutron capture therapy has been designed, constructed, and put into operation at the Massachusetts Institute of Technology Research Reactor (MITR). A fission converter, using plate-type fuel and driven by the MITR, is used as the source of neutrons. After partial moderation and filtration of the fission neutrons, a high-intensity forward directed beam is available with epithermal neutron flux [approximately equal to]10{sup 10} n/cm{sup 2}.s, 1 eV {<=} E {<=} 10 keV, at the entrance to the medical irradiation room, and epithermal neutron flux = 3 to 5 x 10{sup 9} n/cm{sup 2}.s at the end of the patient collimator. This is currently the highest-intensity epithermal neutron beam. Furthermore, the system is designed and licensed to operate at three times higher power and flux should this be desired. Beam contamination from unwanted fast neutrons and gamma rays in the aluminum, polytetrafluoroethylene, cadmium and lead-filtered beam is negligible with a specific fast neutron and gamma dose, D{sub {gamma}}{sub ,fn}/{phi}{sub epi} [less than or approximately equal] 2 x 10{sup -13} Gy cm{sup 2}/n{sub epi}. With a currently approved neutron capture compound, boronophenylalanine, the therapeutically advantageous depth of penetration is >9 cm for a unilateral beam placement. Single fraction irradiations to tolerance can be completed in 5 to 10 min. An irradiation control system based on beam monitors and redundant, high-reliability programmable logic controllers is used to control the three beam shutters and to ensure that the prescribed neutron fluence is accurately delivered to the patient. A patient collimator with variable beam sizes facilitates patient irradiations in any desired orientation. A shielded medical room with a large window provides direct viewing of the patient, as well as remote viewing by television. Rapid access through a shielded and automatically operated door is provided. The D{sub 2}O cooling system for the fuel has been conservatively designed with excess capacity and is fully instrumented to ensure detection and control of off-normal conditions. A wide range of possible abnormal events or accident scenarios has been analyzed to show that even in the worst cases, there should be no fission product release through fuel damage. This facility has been licensed to operate by the U.S. Nuclear Regulatory Commission, and initial operation commenced in June 2000.},
doi = {},
url = {https://www.osti.gov/biblio/20804769}, journal = {Nuclear Science and Engineering},
issn = {0029-5639},
number = 3,
volume = 140,
place = {United States},
year = {Fri Mar 15 00:00:00 EST 2002},
month = {Fri Mar 15 00:00:00 EST 2002}
}